Sanofi on Friday announced it has reached a licensing agreement with Novavax to sell a stand-alone COVID-19 vaccine and ...

QuidelOrtho's new CEO started this week and joined investors during the local diagnostic company's first-quarter earnings ...

Novavax on Friday erased doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion ...

Sanofi on Friday announced it has reached a 'co-exclusive' licensing agreement with Novavax to sell a stand-alone COVID-19 ...

The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to ...

CLEVELAND, Ohio – The number of new COVID-19 cases in Ohio has fallen below the 1,000 mark for the first time since the early ...

A lawsuit filed over a brawl that broke out in a Little Rock restaurant in June 2020 that drew national attention and became ...

Two new omicron subvariants have gained such prevalence in the U.S. that they now account for most of COVID-19 infections in ...

New Delhi: Global public health systems continue to face difficulties as a result of the mutating severe acute respiratory ...

"Oh, the oxygen can heal. We can conceptualize that, but the key is to use it as a vessel to trigger the body to heal itself, ...

(RTTNews) - Sanofi (SNYNF, SNY) and Novavax Inc. (NVAX) announced a co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop Novel COVID-19-Influenza combination vaccines. In ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...